亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Could the PARIS Risk Scores Be Useful for the Choice of Triple versus Dual Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention?

抗血栓 医学 传统PCI 经皮冠状动脉介入治疗 心房颤动 内科学 心脏病学 观察研究 心肌梗塞
作者
Leonardo De Luca,Leonardo Bolognese,Andrea Rubboli,Donata Lucci,Domenico Gabrielli,Furio Colivicchi,Michele Massimo Gulizia
出处
期刊:Cardiology [Karger Publishers]
卷期号:147 (2): 133-136 被引量:3
标识
DOI:10.1159/000521673
摘要

Introduction: Current guidelines recommend dual antithrombotic therapy (DAT) for the majority of patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) and suggest a short course of triple antithrombotic therapy (TAT) for those at very high thrombotic risk (TR) but low bleeding risk (BR). Methods: We analyze if the PARIS ischemic-hemorrhagic scale could be useful for the choice of antithrombotic strategy in patients with acute coronary syndromes and AF treated with coronary stenting enrolled in the prospective, observational, nationwide MATADOR-PCI study. Results: Among the 588 patients discharged alive, a TAT was prescribed in 381 (64.8%) and DAT in 52 (8.8%) patients. According to the PARIS scoring system, 142 (24.2%) were classified as low, 244 (41.5%) as intermediate, and 292 (34.3%) as high TR. In parallel, 87 (14.8%) were categorized in the low, 260 (44.2%) in the intermediate, and 241 (41.0%) in the high-risk stratum for major bleedings. Crossing the various strata of the two PARIS risk scores, the largest group of patients consisted of those at high TR and BR (n = 130, 22%), followed by those at intermediate risk according to both scores (n = 122, 21%). At discharge, TAT was mainly used in patients at intermediate to high BR, while DAT in those at intermediate to high TR but low BR, according to the PARIS score. Conclusion: Our data suggest that some variables associated with increased TR or BR are poorly considered in the daily practice, while the use of PARIS scales could help in the implementation of guidelines’ recommendations.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
摆渡人完成签到,获得积分10
8秒前
提桶跑路完成签到 ,获得积分10
10秒前
温柔的天奇完成签到 ,获得积分10
14秒前
实验耗材完成签到 ,获得积分10
21秒前
22秒前
lhlhl完成签到,获得积分10
26秒前
28秒前
30秒前
小小林发布了新的文献求助10
35秒前
zl13332完成签到 ,获得积分10
35秒前
36秒前
通通完成签到 ,获得积分10
38秒前
hhh完成签到 ,获得积分10
43秒前
51秒前
54秒前
54秒前
SUT文献战神完成签到,获得积分10
56秒前
董可以发布了新的文献求助10
57秒前
小二郎应助董可以采纳,获得10
1分钟前
花陵完成签到 ,获得积分10
1分钟前
含糊的无声完成签到 ,获得积分10
1分钟前
hxn完成签到,获得积分20
1分钟前
1分钟前
小张完成签到 ,获得积分10
1分钟前
jiafang完成签到,获得积分10
1分钟前
scholar丨崔发布了新的文献求助10
1分钟前
want_top_journal完成签到,获得积分10
1分钟前
1分钟前
scholar丨崔完成签到,获得积分10
1分钟前
2分钟前
2分钟前
简单的沛蓝完成签到 ,获得积分10
2分钟前
JIAN完成签到 ,获得积分10
2分钟前
Jasper应助hxn采纳,获得30
2分钟前
xxx完成签到,获得积分10
2分钟前
2分钟前
Green完成签到,获得积分10
2分钟前
斐嘿嘿发布了新的文献求助10
2分钟前
谢丹完成签到 ,获得积分10
2分钟前
寒冷的完成签到,获得积分10
2分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990020
求助须知:如何正确求助?哪些是违规求助? 3532077
关于积分的说明 11256276
捐赠科研通 3270943
什么是DOI,文献DOI怎么找? 1805139
邀请新用户注册赠送积分活动 882270
科研通“疑难数据库(出版商)”最低求助积分说明 809228